An amendment to this paper has been published and can be accessed via the original article.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236118 | PMC |
| http://dx.doi.org/10.1186/s13104-020-05084-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Acute Kidney Failure Confused with Thrombocytopenic Thrombocytic Purpura in Malaria: A Case Report.
Iran J Parasitol
January 2024
Department of Internal Medicine, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Article Synopsis
- Malaria has surged in sub-Saharan Africa due to disruptions from the Covid-19 pandemic, leading to severe cases like cerebral malaria and acute kidney injury.
- A 22-year-old male from Chad, who presented with confusion and had a history of travel to an endemic area, was initially misdiagnosed but later confirmed to have malaria with severe symptoms.
- Successful treatment included intravenous artesunate and hemodialysis, and the patient was discharged after 20 days, highlighting the need for quick diagnosis and effective management of malaria complications.
Correction: Biogenically synthesized green silver nanoparticles exhibit antimalarial activity.
Discov Nano
October 2024
Biomedical Parasitology and Translational-Immunology Lab, Division of Cell Biology and Immunology, CSIR-Institute of Microbial Technology (IMTECH), Sec-39A, Chandigarh, 160036, India.
How to treat patients with thrombotic antiphospholipid syndrome in 2024?
Pol Arch Intern Med
November 2024
Antiphospholipid syndrome (APS) encompasses a range of clinical conditions, particularly thrombotic or obstetrical manifestations, associated with the presence of antiphospholipid antibodies. Managing thrombotic APS in daily clinical practice can be challenging and requires thorough risk stratification and tailored treatment strategies. Primary prophylaxis focuses on correcting the traditional thrombotic risk factors and, in certain situations, may include low‑dose aspirin and / or prophylactic anticoagulants (eg, low‑molecular‑weight heparin).
View Article and Find Full Text PDFDelivery effectiveness of and adherence to intermittent preventive treatment for malaria in pregnancy with dihydroartemisinin-piperaquine with or without targeted information transfer or sulfadoxine-pyrimethamine in western Kenya: a three-armed, pragmatic, open-label, cluster-randomised trial.
Lancet Glob Health
October 2024
Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Article Synopsis
- High resistance to sulfadoxine-pyrimethamine is jeopardizing its effectiveness in preventing malaria in pregnant women, prompting the exploration of dihydroartemisinin-piperaquine as a new treatment alternative in Western Kenya.
- A trial was conducted in 18 antenatal clinics to compare adherence and delivery effectiveness of this new multiday treatment regimen against the standard single-dose treatment, involving random assignment to three different study groups.
- The main focus was to measure adherence by checking how many participants successfully completed the 3-day dihydroartemisinin-piperaquine regimen, verified through home visits and pill counts.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!